2020
Thompson, A L, et al. “The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain.”. J Pharmacol Exp Ther, vol. 373, no. 2, Jan. 2020, pp. 230-8, https://doi.org/10.1124/jpet.119.262337.
Williams, Erica I, et al. “Transporter-Mediated Delivery of Small Molecule Drugs to the Brain: A Critical Mechanism That Can Advance Therapeutic Development for Ischemic Stroke.”. Pharmaceutics, vol. 12, no. 2, Jan. 2020, https://doi.org/10.3390/pharmaceutics12020154.
2019
Stack, Shobha W, et al. “Maternity Leave in Residency: A Multicenter Study of Determinants and Wellness Outcomes.”. Acad Med, vol. 94, no. 11, Nov. 2019, pp. 1738-45, https://doi.org/10.1097/ACM.0000000000002780.
Streicher, John M. “The Role of Heat Shock Proteins in Regulating Receptor Signal Transduction.”. Mol Pharmacol, vol. 95, no. 5, May 2019, pp. 468-74, https://doi.org/10.1124/mol.118.114652.
Bacon, Eliza R, et al. “Neuroendocrine Aging Precedes Perimenopause and Is Regulated by DNA Methylation.”. Neurobiol Aging, vol. 74, Feb. 2019, pp. 213-24, https://doi.org/10.1016/j.neurobiolaging.2018.09.029.
Hay, Meredith, et al. “A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction.”. J Pharmacol Exp Ther, vol. 369, no. 1, Jan. 2019, pp. 9-25, https://doi.org/10.1124/jpet.118.254854.
Thompson, Austen L, et al. “Animal Models for the Study of Bone-Derived Pain.”. Methods Mol Biol, vol. 1914, Jan. 2019, pp. 391-07, https://doi.org/10.1007/978-1-4939-8997-3_23.
Renault, Yohann J G, et al. “Buchwald Hartwig Diversification of Unprotected Halotryptophans, Halotryptophan Containing Tripeptides and the Natural Product Barettin in Aqueous Conditions.”. Chem Commun (Camb), vol. 55, no. 91, Jan. 2019, pp. 13653-6, https://doi.org/10.1039/c9cc02554e.
Moutal, Aubin, et al. “Cdk5-Mediated CRMP2 Phosphorylation Is Necessary and Sufficient for Peripheral Neuropathic Pain.”. Neurobiol Pain, vol. 5, Jan. 2019, https://doi.org/10.1016/j.ynpai.2018.07.003.
Qi, Guoyuan, et al. “Cellular Specificity and Inter-Cellular Coordination in the Brain Bioenergetic System: Implications for Aging and Neurodegeneration.”. Front Physiol, vol. 10, Jan. 2019, p. 1531, https://doi.org/10.3389/fphys.2019.01531.
Olson, Keith M, et al. “Comprehensive Molecular Pharmacology Screening Reveals Potential New Receptor Interactions for Clinically Relevant Opioids.”. PLoS One, vol. 14, no. 6, Jan. 2019, p. e0217371, https://doi.org/10.1371/journal.pone.0217371.
Khanna, Rajesh, et al. “Development and Characterization of An Injury-Free Model of Functional Pain in Rats by Exposure to Red Light.”. J Pain, vol. 20, no. 11, Jan. 2019, pp. 1293-06, https://doi.org/10.1016/j.jpain.2019.04.008.
Wahl, JR, et al. “Migraine, A Review of Basic, Clinical, Translational Approaches to New Treatment”. ARCH Women Health Care, vol. 2, no. 6, Jan. 2019, pp. 1-5.
Chen, Zhoumou, et al. “Sphingosine-1-Phosphate Receptor 1 Activation in Astrocytes Contributes to Neuropathic Pain.”. Proc Natl Acad Sci U S A, vol. 116, no. 21, Jan. 2019, pp. 10557-62, https://doi.org/10.1073/pnas.1820466116.
Lei, Wei, et al. “The Alpha Isoform of Heat Shock Protein 90 and the Co-Chaperones P23 and Cdc37 Promote Opioid Anti-Nociception in the Brain.”. Front Mol Neurosci, vol. 12, Jan. 2019, p. 294, https://doi.org/10.3389/fnmol.2019.00294.
2018
Streicher, John M, and Bilsky, Edward J. “Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.”. J Pharm Pract, vol. 31, no. 6, Dec. 2018, pp. 658-69, https://doi.org/10.1177/0897190017732263.
Zhang, Hong, et al. “Peripherally Restricted Cannabinoid 1 Receptor Agonist As a Novel Analgesic in Cancer-Induced Bone Pain.”. Pain, vol. 159, no. 9, Sept. 2018, pp. 1814-23, https://doi.org/10.1097/j.pain.0000000000001278.
Edwards, Katie A, et al. “A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain.”. J Pain, vol. 19, no. 6, Jan. 2018, pp. 612-25, https://doi.org/10.1016/j.jpain.2018.01.002.
Abdullahi, Wazir, et al. “Blood-Brain Barrier Dysfunction in Ischemic Stroke: Targeting Tight Junctions and Transporters for Vascular Protection.”. Am J Physiol Cell Physiol, vol. 315, no. 3, Jan. 2018, pp. C343-C356, https://doi.org/10.1152/ajpcell.00095.2018.
Pandit, Viraj, et al. “Continuous Remote Ischemic Conditioning Attenuates Cognitive and Motor Deficits from Moderate Traumatic Brain Injury.”. J Trauma Acute Care Surg, vol. 85, no. 1, Jan. 2018, pp. 48-53, https://doi.org/10.1097/TA.0000000000001835.
Williams, Sigrid G, et al. “Effects of Legislation Regulating Abortion in Arizona.”. Womens Health Issues, vol. 28, no. 4, Jan. 2018, pp. 297-00, https://doi.org/10.1016/j.whi.2018.02.002.
Cottier, Karissa E, et al. “Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery.”. ENeuro, vol. 5, no. 4, Jan. 2018, https://doi.org/10.1523/ENEURO.0116-18.2018.
Olson, Keith M, et al. “Synthesis and Evaluation of a Novel Bivalent Selective Antagonist for the Mu-Delta Opioid Receptor Heterodimer That Reduces Morphine Withdrawal in Mice.”. J Med Chem, vol. 61, no. 14, Jan. 2018, pp. 6075-86, https://doi.org/10.1021/acs.jmedchem.8b00403.
Shah, Nirav, et al. “TAK1 Activation of Alpha-TAT1 and Microtubule Hyperacetylation Control AKT Signaling and Cell Growth.”. Nat Commun, vol. 9, no. 1, Jan. 2018, p. 1696, https://doi.org/10.1038/s41467-018-04121-y.
2017
Keresztes, Attila, and Streicher, John M. “Synergistic Interaction of the Cannabinoid and Death Receptor Systems - a Potential Target for Future Cancer Therapies?”. FEBS Lett, vol. 591, no. 20, Oct. 2017, pp. 3235-51, https://doi.org/10.1002/1873-3468.12863.